Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Coagulation Status and Thromboelastometry Guided Management of Genetic and Acquired Thrombophilia in Patients With Portal Vein Thrombosis and Budd-Chiari Syndrome

NCT05123326 is registered in ClinicalTrials.gov with Post Graduate Institute of Medical Education and Research, Chandigarh as lead sponsor.

NCT NCT05123326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05123326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Coagulation Status and Thromboelastometry Guided Management of Genetic and Acquired Thrombophilia in Patients With Portal Vein Thrombosis and Budd-Chiari Syndrome
Lead sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase
Observational
Overall status
Unknown status
Start date
October 15, 2021
Completion date
October 15, 2024
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants and bleeding disorders, calr gene mutation, hepatic vein thromboses, hepatic venous outflow obstruction, jak2 mutation, portal hypertension, noncirrhotic, portal vein embolism, portal vein occlusion, portal vein thrombosis, prothrombin g20210a